StockNews.AI
OABI
StockNews.AI
176 days

OmniAb to Report Fourth Quarter 2024 Financial Results on March 18

1. OmniAb to report Q4 and full-year 2024 financial results; conference call scheduled. 2. Report release set for March 18, 2025 post-market; business updates to follow.

Earnings
-0.55%Current Return
VS
-0.74%S&P 500
$3.6502/24 08:14 AM EDTEvent Start
$3.6302/25 03:05 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

The announcement is a standard earnings report schedule. Historically, earnings announcements by biotech firms like OmniAb have minimal immediate impact until results are revealed, making the immediate price impact neutral.

How important is it?

The scheduled earnings announcement is a key event that investors monitor. Its impact on OABI price will depend on reported financials, making it moderately important.

Why Short Term?

Earnings releases tend to drive short-term price volatility. Similar biotech earnings events have led to rapid price adjustments within days.

Related Companies

EMERYVILLE, Calif.--(BUSINESS WIRE)--OmniAb, Inc. (NASDAQ: OABI) will report financial results for the three and 12 months ended December 31, 2024 after the close of the U.S. financial markets on Tuesday, March 18, 2025 and will hold a conference call that same day beginning at 4:30 p.m. Eastern time. Conference Call and Webcast Information What:   OmniAb conference call to discuss fourth quarter financial results and business updates       Date:   Tuesday, March 18, 2025       Time:   4:30 p.m.

Related News